PIK3CD and neoplasm: CNB is a novel, intravenous PI3K inhibitor used to treat different solid and hematological malignancies.9,10 CNB induces tumor cell death such as apoptosis, and inhibits primary malignant B cell proliferation and tumor growth in the preclinical xenograft tumor models of malignant B cell.11